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Chemical mutagenesis in the mouse is a powerful approach for phenotype-driven genetics, but questions
remain about the efficiency with which new mutations ascertained by their phenotype can be localized and
identified, and that knowledge applied to a specific biological problem. During a global screen for dominant
phenotypes in about 30,000 animals, a novel class of pigmentation mutants were identified by dark skin (Dsk).
We determined the genetic map location, homozygous phenotype, and histology of 10 new Dsk and 2 new
dark coat (Dcc) mutations, and identified mutations in Agouti (Met1Leu, Dcc4), Sox18 (Leu220ter, Dcc1),
Keratin 2e (Thr500Pro, Dsk2), and Egfr (Leu863Gln, Dsk5). Cutaneous effects of most Dsk mutations are
limited to melanocytes, except for the Keratin 2e and Egfr mutations, in which hyperkeratosis and epidermal
thickening precede epidermal melanocytosis by 3–6 wk. The Dsk2 mutation is likely to impair intermediate
filament assembly, leading to cytolysis of suprabasal keratinocytes and secondary hyperkeratosis and
melanocytosis. The Dsk5 mutation causes increased tyrosine kinase activity and a decrease in steady-state
receptor levels in vivo. The Dsk mutations represent genes or map locations not implicated previously in
pigmentation, and delineate a developmental pathway in which mutations can be classified on the basis of
body region, microscopic site, and timing of pigment accumulation.
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Phenotype-driven genetics in model organisms is a pow-
erful approach for dissecting molecular pathways rel-
evant to human disease. In the mouse, specific pathways
identified through studies of so-called “classical” mouse
mutations such as limb deformity, microphthalmia,
Splotch, or White spotting has provided momentum for
large-scale chemical mutagenesis programs (Bedell et al.
1997; Justice et al. 1999; Balling 2001), intended to in-
crease the number of genetic entry points for studying
many different organ systems and physiologic processes
(Hrabé de Angelis et al. 2000; Nolan et al. 2000; Shiroishi
2001).
The pigmentary system plays a prominent role in this
endeavor. Melanocytes are nonessential cells in which
small changes in gene expression are readily detected by
simple visual inspection, and many of the developmen-
tal and physiologic pathways used by pigment cells have
parallels in other less-accessible cell types such as germ
cells or neurons (Silvers 1979; Jackson 1997). Model sys-
tems based on coat color have provided insight into rare
disorders such as immunodeficiency and albinism in
Chediak-Higashi syndrome, development of the enteric
nervous system and piebaldism in Shah-Waardenburg
syndrome, as well as for common human diseases like
obesity or skin cancer (Jackson 1997; Spritz 1999).
Nearly all pigment mutations in mice have been iden-
tified by their effects on hair color, whereas only a few
are known to alter skin color. In part, this difference is
due to a bias in ascertainment; hair melanocytes are
more numerous than skin melanocytes, with the latter
confined mainly to nonhairy regions such as the footpads
or tail (Quevedo and Holstein 1998). However, several
considerations suggest that variation in mouse skin
color is amenable to Mendelian genetics, and may offer
the opportunity to model biological processes distinct
from those surveyed by coat color mutations. Overex-
pression of hepatocyte growth factor (Kunisada et al.
2000) or Hras1 (Broome Powell et al. 1999) in transgenic
mice causes dark skin, accumulation of dermal melano-
cytes, and increased susceptibility to melanoma, but
genes that impinge on HGF or Ras signaling have not
been identified as coat color mutations. In addition, a
recently described recessive mutation, sooty foot, causes
dark skin due to increased epidermal pigmentation (Budd
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et al. 1997); the gene mutated in sooty foot has not been
identified, but is not allelic with previously known coat
color mutations. Finally, most coat color mutations in-
volve processes that act relatively early in development
of the pigmentary system, in the case of white-spotting,
or relatively late, in the case of defects in melanogenesis,
melanosome biogenesis, or pigment type-switching (Sil-
vers 1979). In contrast, changes in skin color depend on
a different set of processes that occur after neural crest
differentiation but before mature hair growth (see be-
low).
Among three large-scale programs for chemical muta-
genesis of the mouse genome carried out in England (No-
lan et al. 2000), Germany (Hrabé de Angelis et al. 2000),
or Japan (Shiroishi 2001), a significant proportion of phe-
nodeviants show dark skin or hair; additional informa-
tive phenodeviants can be expected from current mu-
tagenesis projects in the USA and Australia. Here, we
describe a genetic, pathologic, and molecular character-
ization of 10 dark skin (Dsk) and 2 dark coat color (Dcc)
mutants identified in the German screen. Among the
Dsk mutations, we find one, Dsk2, which represents a
new human disease model for ichthyosis bullosa of Si-
emens (IBS), a dominant keratin disorder, and another,
Dsk5, which represents a novel gain-of-function allele in
the epidermal growth factor receptor (Egfr) oncogene.
The Dcc mutations are new alleles of “classical” loci,
but the Dsk mutations map to locations in the genome
not previously associated with pigmentation pheno-
types, and identify distinct steps in a previously unap-
preciated developmental pathway. These results provide
one of the larger molecular characterizations of a pheno-
type-driven chemical mutagenesis screen to date, and
demonstrate how the genetics of dark skin can be used to
investigate general mechanisms of mammalian develop-
ment and disease.
Results
Different effects of dermal versus epidermal
pigment accumulation
As skin appendages are formed late in gestation, a com-
mitted population of pigment cell precursors, melano-
blasts, is found amid mesenchymal cells in the develop-
ing dermis; some of these melanoblasts remain in the
dermis and differentiate into dermal melanocytes,
whereas others migrate across the dermal–epidermal
junction. Epidermal melanoblasts may differentiate into
hair follicle melanocytes or extrafollicular skin melano-
cytes (Yoshida et al. 1996). Ultimately, each type of
cell—dermal melanocyte, follicular melanocyte, and epi-
dermal extrafollicular melanocyte—is distinct with re-
gard to its morphology (Quevedo and Holstein 1998), pat-
tern of cadherin expression (Nishimura et al. 1999; Jou-
neau et al. 2000), and competence to synthesize certain
types of pigment (Silvers 1979). Thus, there are multiple
developmental steps that, when perturbed, might cause
changes in skin pigmentation (Fig. 1a; Yoshida et al.
2001).
The Dsk mutations described here were all identified
by the presence of excess footpad pigmentation in het-
erozygous animals (Fig. 2a), but careful examination re-
vealed unique aspects to the different lines. As shown in
Figure 2 and summarized in Table 1, there are 2 broad
phenotypic categories. Footpads fromDsk1,Dsk7,Dsk9,
and Dsk10 (Class I, Fig. 2b) have excess pigment in a
uniform and continuous slanted stripe that is especially
Figure 1. Developmental genetics of dark
skin. (a) Between embryonic day 12 (E12)
and postnatal day 10 (P10), neural crest-
derived melanoblasts (Mb) migrate into
the developing dermis (blue), and either
differentiate into dermal melanocytes
(Mc, 1) or continue migrating into the epi-
dermis (pink, 2). Between E16 and P10,
epidermal melanoblasts can differentiate
into intrafollicular melanocytes that are
responsible for adult hair color (3), differ-
entiate into interfollicular melanocytes
that are responsible for neonatal skin color
but disappear by 2 wk of age or in nonhairy
regions of the skin and in the tail (4), dif-
ferentiate into epidermal melanocytes
that persist through adult life (5), and in-
crease in number and/or activity in re-
sponse to environmental signals such as
UV irradiation (Rosdahl 1979) or wound
healing (Hirobe 1988). Timing of these
stages is based on Quevedo and Holstein (1998) and Yoshida et al. (1996), and our own unpublished studies (C.D. van Raamsdonk and
G.S. Barsh, unpubl.). (b) Dsk1, Dsk7, Dsk9, and Dsk10 cause an increase in dermal melanocytes (1); Dsk1, Dsk7, and Dsk10 also cause
a slight darkening of hair (data not shown). Dsk3, Dsk4, Dsk6, and Dsk8 cause melanin to accumulate in nonhairy regions of the
epidermis; the phenotype is apparent by 2–3 wk of age. Dsk2 and Dsk5 cause an increased number of epidermal melanocytes, but the
phenotype is not apparent until 6–8 wk of age.
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prominent over the volar pad at the base of the first digit
(but not other volar pads) and has a bluish-gray color. In
contrast, footpads from Dsk2, Dsk3, Dsk4, Dsk5, Dsk6,
and Dsk8 (Class II, Fig. 2c) have excess pigment with a
brown hue distributed in small punctate patches on
most or all of the volar pads. In addition, excess pigment
in the Class II mutants is found on phalangeal ridges and
intervolar pad scales; structures with an epidermal com-
ponent normally subject to high levels of friction.
The distinction between broad phenotypic classes on
the basis of footpad pigmentation extends to other re-
gions of the body (Table 1). In particular, Dsk1, Dsk7,
and Dsk10 (class I mutants) are darker than most of the
other mutants in ear and tail skin (Fig. 2e; data not
shown), and, unlike the other mutants, cause a slight
darkening of hair in addition to skin (data not shown).
The developmental basis for the class I phenotype be-
came apparent upon histologic examination of skin from
mutant animals, which revealed normal patterns of pig-
ment deposition in the epidermis, but a dramatic accu-
mulation in the dermis (Fig. 3). Increased dermal pig-
ment in Dsk1, Dsk7, and Dsk10 is apparent by 2–3 d of
age, progresses through weaning, and gradually dimin-
ishes in older animals. This suggests that the decision of
dermal melanoblasts to differentiate in situ or migrate
across a basement membrane, which normally takes
place between E12.5 and P10, is perturbed by Dsk1 and
Dsk7, but has a very similar phenotype (Table 1); its map
position (see below) overlaps with that of Dsk1; thus, all
three mutations, Dsk1, Dsk7, and Dsk10 are likely to
affect the same underlying process.
The class II Dsk mutants, grouped on the basis of their
footpad phenotypes, show more heterogeneity in other
body regions than the class I mutants. For example,Dsk2
mutant tails are scaly, Dsk3 mutant tails are dark, and
tails from the other class II mutants are mildly affected
or normal. Nonetheless, the class II mutants share a
common histologic phenotype that is opposite to that of
class I, with little or no excess pigment in the dermis,
but a dramatic accumulation in the epidermis (Fig. 3).
Increased pigmentation in the class II mutants also has a
later onset than in most of the class I mutants. Dsk3,
Dsk4, Dsk6, and Dsk8 (class II) are evident at weaning,
whereas Dsk2 and Dsk5 (class II) are not apparent until
Figure 2. Footpad and tail phenotype of Dsk1–Dsk9. At 4 wk of age, footpads from C3HeB/FeJ nonmutant mice (a) have little or no
pigment, whereas footpads from Dsk1, Dsk7, and Dsk9 (b) exhibit a continuous bluish-gray stripe. Footpads from Dsk2, Dsk3, Dsk4,
Dsk5, Dsk6, and Dsk8 (c) exhibit punctate accumulation of pigment with a brown hue on the volar pads, intervolar scales, and
phalangeal ridges. (The footpad images for Dsk2 and Dsk5 are from animals 3 and 5 mo of age, respectively.) The footpad patterns fall
into two broad categories that correlate with the microscopic site of pigment accumulation in the dermis (Class I) or epidermis (Class
II); however, the tail phenotypes (d–f) are more variable. Tails ofDsk1 andDsk7 (e) are extremely dark in both the scales and interscale
regions; tails of Dsk3 (f) are extremely dark but only within the scales; tails of Dsk4, Dsk6, and Dsk8 are moderately dark and can be
easily distinguished from nonmutant littermates; and Dsk5 and Dsk9 show little or no excess tail pigmentation. In Dsk2, hyperkera-
tosis and intraepidermal cytolysis (Fig. 4, below) cause an overall scaly appearance.
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6–12 wk of age. Hyperpigmentation in all of the class II
mutants also becomes more severe with age, which sug-
gests that one or more of the class II mutants affects the
decision of epidermal melanoblasts to proliferate and/or
differentiate in situ (Fig. 1a).
Genetic map locations and homozygous phenotypes
of Dsk mutants
Establishing the genetic map location for each Dsk mu-
tant allowed us to investigate allelism to each other or
previously existing mutations, to determine the homo-
zygous phenotype, and to identify potential candidate
genes. We used a panel of 60 SSLP markers to scan 16–40
(C3HeB/FeJ–Dsk/+ × C57BL/6J)F1 × C3H back-cross
progeny for each of the Dsk mutants, and subsequently
narrowed each location to a small interval by use of ad-
ditional markers and additional back-cross progeny
(Table 1).
The 10 Dsk mutants map to 8 different locations; all
are distinct from previously existing coat color muta-
tions (Table 1). Dsk6 and Dsk8map to the same interval
and exhibit very similar phenotypes, as do Dsk1 and
Dsk10; thus, even in this relatively small collection,
there is evidence for multiple alleles per gene. With the
exception of Dsk2 and Dsk5 (see below), the map loca-
tions do not immediately suggest positional candidates,
but do provide a means for unambiguous determination
of homozygous phenotypes.
Homozygotes for three of the class I mutants, Dsk1,
Dsk7, and Dsk10, show abnormalities qualitatively
similar but quantitatively more severe than the hetero-
zygotes, with increased accumulation of dermal pigment
in the ears, tail, and footpads, as well as in hairy skin
(data not shown). In contrast, homozygotes for Dsk3,
Dsk4, Dsk6, Dsk8, and Dsk9 die prior to birth. Thus,
some processes affected by Dsk mutations are limited to
the skin, whereas others are required for embryonic vi-
ability.
Melanocytosis in a model for a human
keratin disorder
Tail, footpad, and ear skin inDsk2mutant animals is not
only dark but also scaly (Fig. 2). Both pigmentation and
scaling phenotypes are apparent, and similar in quality,
in heterozygotes compared with homozygotes. However,
scaling is evident by 3–4 wk of age (Fig. 4a,b), whereas
pigment accumulation does not appear until 3–6 wk




positiona MolecularbFeetc Tailc Earsc Timingd Otherd Histologyd Homozygote





Dsk2 ++ ++ ++ 6 wk; darkens with
age




15 (58) Keratin 2e:
Thr500Pro
Dsk3 ++ +++ ++ 2 wk; darkens with
age
small size Epidermal embryonic lethal 7 (6) —
Dsk4 ++ ++ + 2 wk; darkens with
age
none Epidermal embryonic lethal 4 (1) —
Dsk5 ++ + + 8–12 wk; darkens
with age
wavy hair; long nails Epidermal similar to
heterozygote
11 (9) Egfr: Leu863Gln
Dsk6 + ++ + 3 wk; darkens with
age
small size; dark nails Epidermal embryonic lethal 3 (66) —







Dsk8 + ++ + 3 wk; darkens with
age
small size; dark nails Epidermal embryonic lethal 3 (66) —
Dsk9 + + + 3 wk; fades slightly
with age
dark perineum Dermal embryonic lethal 11 (46) —
Dsk10 +++ +++ +++ 3 d; fades with age dark hair Dermal darker than
heterozygote
19 (15) —
Dcc1 NA NA NA 2 wk sparse hair NA small size; sparse hair 2 (95) Sox18: Leu220Stop
Dcc4 NA NA NA 2 wk none NA dark hair 2 (90) Agouti: Met1Leu
aMap position is given as the chromosome location followed, in parentheses, by the position in centiMorgans from the centromere; flanking markers (1–5
cM) are given in Materials and methods.
bMolecular abnormalities were identified for Dsk2, Dsk5, Dcc1, and Dcc4, as described in Results.
cThe extent of skin darkening apparent from gross inspection of 3–4 week-old animals was graded as slightly darker than nonmutant (+), moderately dark
(++), or extremely dark (+++).
dWe describe each mutant according to when visible darkening is first evident, whether or not darkening increases or fades with age, if other body regions
are visibly affected, and the microscopic site at which pigment accumulates in the footpads of 4–6-week-old animals. Classification of pigment accu-
mulation as dermal or epidermal is based on examination of hematoxylin and eosin-stained sections from multiple animals for each line; representative
photomicrographs are displayed in Figure 3.
eDsk7 homozygotes exhibit a large increase in dermal pigmentation and a slight increase in epidermal pigmentation.
fDsk1–Dsk9 were characterized at Stanford; Dsk10 was characterized initially at Institut de Transgenose. Comparison of their features suggests that
Dsk10 is a class I mutation (Fig. 2) very similar to Dsk1 and Dsk7.
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later (Fig. 4c,d,e), suggesting that excess pigment depo-
sition is secondary to a keratinocyte defect.
Histologically, Dsk2 footpads at 1 mo of age (Fig. 4a,b)
and tails (data not shown) exhibit a thickened epidermis
and cytolysis in the upper spinous and granular layers.
By 2 mo of age, excess pigment in Dsk2 mutant skin is
found throughout epidermal keratinocytes in a typical
perinuclear distribution but at greatly increased levels
compared with normal (Fig. 4c,d,e). To determine
whether excess pigmentation was caused by an increase
in melanocyte number, we made use of a transgenic re-
porter, Tg.DctLacZ (Mackenzie et al. 1997), whose ex-
pression in the epidermis is confined to pigment cells.
Compared with footpads of nonmutant littermates,
which had few or no lacZ-positive cells at 2 mo of age
(Fig. 4c), footpads of Dsk2/+; Tg.DctLacZ mice showed
increased numbers of melanocytes in areas that coin-
cided with increased epidermal melanin (Fig. 4d,e).
The Dsk2 histologic phenotype is reminiscent of
dominant keratin disorders caused by point mutations
that disrupt intermediate filament assembly, and the
5-cM interval to which we mapped Dsk2, D15Mit42–
D15Mit246, includes the basic keratin complex. Among
a minimum of 10 keratin genes in this complex, we con-
sidered keratin 1 (Krt1) and Keratin 2e (Krt2e) as the
most likely candidates, because they are expressed spe-
cifically in the suprabasal epidermis and because mis-
sense mutations cause epidermal thickening and su-
prabasal blistering in the human diseases epidermolytic
hyperkeratosis (KRT1) and ichthyosis bullosa of Siemens
(KRT2E; Fuchs 1996; Arin and Roop 2001).
Using PCR amplification from genomic DNA of Dsk2
homozygotes, protein-coding regions of Krt1 were nor-
mal, but in Krt2e, we identified a missense mutation
that predicts a Thr500Pro substitution in the rod 2B do-
main, a region known to be important for keratin–kera-
tin interactions (Fig. 4f). Remarkably, the same amino
acid substitution was reported in a patient with ichthyo-
sis bullosa of Siemens (Yang et al. 1997), a dominant
disorder characterized by the presence of widespread
blistering at birth with later development of flexural hy-
perkeratoses (Traupe et al. 1986; Steijlen et al. 1990).
Skin abnormalities in Dsk2 mutants are confined to the
tails, ears, and footpads, and we have never observed blis-
tering in mutant animals; however, the intra-epidermal
level at which cytolysis occurs in Dsk2 mutant skin is
nearly identical to that which occurs in ichthyosis bul-
losa of Siemens. These observations suggest that Keratin
Figure 3. Histologic site of pigment accumulation in representative dark skin mutants. Footpad sections from 4-week-old C3HeB/FeJ
nonmutant (a,d,g), Dsk1 (b,e,h), and Dsk3 (c,f,i) animals. Drawings at left depict the location of the sections; volar pads (a–f) or
intervolar scales (g–i). Dermal accumulation of pigment shown for Dsk1 is similar to that which occurs in Dsk7, Dsk9, and Dsk10;
epidermal accumulation of pigment shown for Dsk3 is similar to that which occurs in Dsk4, Dsk6, and Dsk8. Bars: a–c, 100 µm; d–f,
25 µm.
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2e is specialized for the upper spinous layer of the epi-
dermis in both humans and mice, but that the body re-
gions and developmental times at which specialization
is required differ between species (Herzog et al. 1994;
Smith et al. 1999).
A hypermorphic mutation in the Egfr
Like Dsk2, excess footpad pigmentation in Dsk5mutant
animals becomes apparent only in adult animals and
progresses with age. The pigmentary effects of Dsk5 are
restricted to the footpads; in addition, some Dsk5 mu-
tant animals show increased nail length (Fig. 5c). Histo-
logically, the epidermis in Dsk5 skin is thickened, with
a pattern of excess pigment deposition and an increased
number of melanocytes in the epidermis similar to Dsk2
(Fig. 5d). Also, like Dsk2, hyperkeratosis occurs before
pigment accumulation; at 1 mo of age, Dsk5/+ skin is
mildy thickened compared with +/+ skin, at 2 mo of age,
Dsk5/+ skin shows increased thickening and mild hyper-
pigmentation, and by 6 mo of age, Dsk5/+ skin exhibits
obvious pigment accumulation and melanocytosis (Fig.
5e–j).
We mapped Dsk5 to a 10-cM interval, D11Mit2–
D11Mit294, which includes the epidermal growth factor
receptor (Egfr) gene. Disturbances in Egfr signaling have
not been associated previously with pigmentary abnor-
malities, but are well known to cause defects of hair
follicle architecture in animals homozygous for the
Tgfawa1 or Egfrwa2mutations (Mann et al. 1993; Luetteke
et al. 1994), and close inspection of Dsk5 mutant ani-
mals revealed a wavy coat in 3-week-old animals that
became less apparent with age. In PCR-amplified liver
cDNA from Dsk5 homozygotes, we identified a mis-
sense mutation that predicts a Leu863Gln substitution;
this site lies within the tyrosine kinase domain and is
conserved among all mammalian Egfr family members
(Erbb2, Erbb3, and Erbb4), as well as distantly related
receptor tyrosine kinases c-abl, c-src, the Drosophila ho-
molog Torpedo, and the Caenorhabditis elegans homo-
log Let-23 (Fig. 6a). On the basis of the recently reported
crystal structure of the human Egfr kinase domain (Sta-
mos et al. 2002), the Leu863Gln substitution lies within
a three-residue -strand that helps to stabilize the acti-
vation loop, an extended surface feature characteristic of
all tyrosine kinases that interacts with both the catalytic
site and the ATP-binding site (Fig. 6b).
Some effects of Egfr on the skin are thought to repre-
sent paracrine or autocrine activity within keratino-
cytes; however, Egfr expression has also been reported
in cultured melanocytes (Gordon-Thomson et al. 2001)
and in melanoma cells (Mattei et al. 1994). To compare
Figure 4. Histologic and molecular char-
acterization of Dsk2. (a,b) Hematoxylin
and eosin-stained footpad sections from
1-month-old C3HeB/FeJ nonmutant (a)
and Dsk2/+ (b) littermates. Dsk2 mutant
footpads have a thickened epidermis and
exhibit cytolysis in suprabasal layers. (c–e)
Xgal- and eosin-stained footpad sections
from 2-month-old nonmutant (c) and
Dsk2/+ (d,e) animals that carry the Dct-
LacZ reporter transgene. Dsk2 mutants
show increased numbers of epidermal me-
lanocytes that correlate with sites of ex-
cess pigment deposition. (f) An A-to-C
transversion in genomic DNA of Dsk2
animals predicts a Thr-to-Pro substitution
in the rod 2B domain of Krt2e. The exact
same amino acid change has been de-
scribed in a patient with ichthyosis bul-
losa of Siemens (Yang et al. 1997). Bars,
50 µm.
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the relative levels of Egfr expression in melanocytes
and keratinocytes, we examined skin sections from
Tg.DctLacZ/+ animals doubly stained with Xgal and an
Egfr antibody. In the footpads (Fig. 7a) and tail (data not
shown), there is strong immunostaining for Egfr
throughout all keratinocyte layers, but no obvious im-
munostaining of melanocytes. Taken together with the
observation that hyperkeratosis becomes apparent 3–4
wk before pigment accumulation, these findings suggest
that epidermal melanocytosis caused by Dsk5 is not a
direct response of altered Egfr signaling, but, instead, is
secondary to increased keratinocyte proliferation and
epidermal thickening.
Previously described alleles of the endogenous Egfr
Figure 5. Histologic characterization of
Dsk5. (a–d) Footpad sections from 6-
month-old nonmutant (a,b) and Dsk5/+
littermates carrying the DctLacZ reporter
transgene (c,d) were stained with Xgal and
eosin (b,d). The mutant footpad exhibits
increased pigmentation on the volar pads,
epidermal thickening, and deepening of
the rete pegs. Comparison of hematoxylin
and eosin-stained footpad sections from
isogenic nonmutant and Dsk5/+ litter-
mates at 1, 2, and 6 mo of age (e–j) shows
that epidermal thickening develops by 1–2
mo of age, whereas hyperpigmentation
does not develop until 2 mo of age. Bars,
50 µm.
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gene all cause a loss-of-function, with phenotypic mani-
festations either limited to homozygotes or, in the case
of a dominant negative mutation, causing homozygous
lethality (Luetteke et al. 1994; Threadgill et al. 1995;
Thaung et al. 2002).Dsk5 differs from these loss-of-func-
tion mutations in several respects. Homozygotes for
Dsk5 are viable and fertile, with cutaneous phenotypes
similar to heterozygous animals, and Egfr loss-of-func-
tion alleles cause a thinning of the epidermis, whereas
theDsk5mutant animals display a thickened epidermis.
Hyperkeratosis and epidermal thickening has also been
described in animals that carry a Tgfa transgene driven
by the keratin 14 promoter, and, therefore, might be ex-
plained by Egfr gain-of-function, as Tgfa is an Egfr ligand
(Vassar and Fuchs 1991). To investigate genetically
whether Dsk5 represented a loss- or gain-of-function
mutation, we examined progeny of a Dsk5/+ × Egfrwa2/+
cross. The Egfrwa2 allele is hypomorphic; it is caused by
a missense substitution in the kinase domain that does
not affect protein levels but severely impairs ligand-in-
duced Egfr signaling (Luetteke et al. 1994; Fowler et al.
1995). We reasoned that if Dsk5 represents a loss-of-
function, then a hypomorph such as Egfrwa2 would en-
hance the mutant phenotype, but if Dsk5 represents a
gain-of-function, then a hypomorph would rescue or
ameliorate the mutant phenotype. We examined 14
Dsk5/Egfrwa2 and 18 Dsk5/+ animals in a consistent ge-
netic background at 3–12 mo of age; in every case, foot-
pad pigmentation of Dsk5/Egfrwa2 animals was lighter
than their Dsk5/+ littermates (Fig. 7b,c,d). Amelioration
of the Dsk5 mutant phenotype by Egfrwa2 indicates that
Dsk5 is hypermorphic, and suggests that the Leu863Gln
alteration causes increased Egfr signaling.
To determine the effect of the Dsk5 mutation on Egfr
activity, we examined levels of protein and mRNA ex-
pression, and measured ligand-induced autophosphory-
lation in liver extracts, in which endogenous levels of
Egfr can be detected easily by immunoblotting. We
found that Dsk5 caused a dose-dependent decrease in
Egfr protein; liver extracts from Dsk5/+ animals contain
∼ 50% of the normal amount, whereas extracts from ho-
mozygous mutants are reduced by ∼ 90% (Fig. 7e). In con-
trast,Dsk5 has no detectable effect on Egfr mRNA levels
(Fig. 7f), which suggests that the Leu863Gln alteration
either impairs protein translation or causes increased re-
ceptor turnover (Felder et al. 1992). Using an antiphos-
photyrosine antibody to probe immunoblots of liver ex-
tracts, basal levels of phosphorylated Egfr were undetect-
able in +/+, Dsk5/+, and Dsk5/Dsk5 mutant animals
(Fig. 7g,h). However, subcutaneous administration of Egf
induced a rapid increase in levels of phosphorylated Egfr
that were similar in +/+ andDsk5/+ animals, and slightly
reduced in Dsk5/Dsk5 animals (Fig. 7g,h). Thus, Dsk5
causes an increase in the proportion of Egfr that becomes
phosphorylated in response to ligand. We also examined
the response of phosphorylated and total Egfr levels in
Dsk5/+ and +/+ mice to different levels of Egf, and to
pretreatment with a phosphatase inhibitor (data not
shown), and observed no differences between mutant
and nonmutant animals other than the relative increase
in phosphorylation. Finally, we expressed the normal
and Leu863Gln mutant Egfr in cultured cells and com-
Figure 6. An Egfr mutation in Dsk5. (a) A T-to-A transversion in genomic DNA of Dsk5 animals predicts a Leu-to-Gln substitution
in the kinase domain of Egfr. Numbering is based on the full-length mouse precursor protein. Leu 863 is highly conserved in all Erbb
family members, as well as more distantly related receptor tyrosine kinases such as c-abl, Src, Torpedo (Drosophila), and Let 23 (C.
elegans). (b) Position of the Leu863Gln substitution mapped onto the three-dimensional structure of the human Egfr tyrosine kinase
domain; Leu 863 corresponds to Leu 837 in the scheme of Stamos and Eigenbrot (Stamos et al. 2002). The N- and C-terminal domains
are colored pink and blue, respectively, and key regions for kinase function are colored yellow, green, and red as indicated. Side chains
are indicated for Lys 862, Leu 863, and Tyr 871; -strand hydrogen bond interactions from Lys 862 to Leu 864 and hydrophobic
interactions between Lys 862 and Tyr 871 play key roles in maintaining the conformation of the activation loop (Stamos et al. 2002).
Coordinates are from PDB 1M14, and are displayed with Cn3D.
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pared the levels of expression and autophosphorylation.
Under the conditions used for transient transfection, we
found no difference in levels of mutant and normal Egfr
protein (Fig. 7i), which demonstrates that the Leu863Gln
mutation does not impair Egfr translation, and suggests
that the mechanisms responsible for reduced expression
Figure 7. Genetic and biochemical mechanisms of Dsk5 action. (a) Xgal and Egfr immunostaining of a footpad section from a
3-month-old animal carrying the DctLacZ transgene (top); Xgal alone without primary antibody (bottom). (b–d) Footpad phenotypes
from 4-month-old +/+ (b), Dsk5/+ (c), and Dsk5/Egfrwa2 (d) littermates shows that a reduction of Egfr signaling caused by the Egfrwa2
allele suppresses the pigmentary phenotype of Dsk5. Results are representative of 14 Dsk5/wa2 and 18 Dsk5/+ animals from multiple
litters examined at 3–12 mo of age; Egfrwa2/+ animals show no skin (or any other) phenotype. (e) Western blots of liver protein extracts
from isogenic +/+, Dsk5/+, or Dsk5/Dsk5 adult animals probed with anti-Egfr. (f) Semiquantitative RT–PCR for an Egfr cDNA
fragment prepared from livers of +/+ or Dsk5/Dsk5 animals. (g) EGF-induced autophosphorylation of Egfr in vivo. Seven-day-old
iosgenic +/+ or Dsk5/+ littermates were injected with EGF as described in Materials and Methods; Western blots were probed
sequentially with an antiphosphotyrosine antibody (PY20) and an anti-Egfr antibody, as indicated. (h) Same experiment as in g using
1-month-old isogenic +/+ or Dsk5/Dsk5 animals. Results shown are representative of four normal, four heterozygous, and two
homozygous mutant animals. (i) Levels of Egfr and Egfr autophosphorylation for the nonmutant (+) and Dsk5 Leu863Gln Egfr protein
as determined by Western blot analysis of extracts from cultured cells transiently transfected with 1 or 2 µg of plasmid vector as
indicated.
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in vivo (Fig. 7e,g,h) are not represented in cultured cells
that transiently express high levels of the receptor. More
important, there is a 5- to 10-fold increase in basal levels
of autophosphorylation (Fig. 7i).
Taken together with the genetic data (Fig. 7a–c), these
observations confirm that increased kinase activity is
associated with the Leu863Gln alteration, and help to
explain why Dsk5mutant animals develop hyperkerato-
sis and epidermal thickening. The reasons whyDsk5 and
Egfrwa2 should both cause a wavy coat are not clear, but
could represent a general response to alteration of epi-
dermal thickness (in either direction), and/or effects of
Egfr signaling on hair keratinocytes.
Molecular characterization of Dcc1 and Dcc4
In addition to the 10 dark skin mutants described above,
we examined 2 dark coat color mutants, Dcc1 and Dcc4,
generated during the same screen. Both the genetic map
location and phenotype of Dcc1 suggested it was an al-
lele of Ragged, a classical mouse mutation shown re-
cently (Pennisi et al. 2000) to be caused by mutations in
the Sry-related transcription factor Sox18. Dcc1 hetero-
zygotes show reduced agouti banding on dorsal hairs,
whereas homozygotes showed sparse hair growth and a
complete absence of yellow pigment on the trunk (Fig.
8a–c). PCR amplification of genomic DNA from Dcc1
homozygous animals revealed a nonsense mutation,
Leu220ter, in the transactivation domain (Fig. 8d). Three
other naturally occurring alleles of Sox18 have been de-
scribed with similar phenotypes; all are frameshift mu-
tations that occur within seven codons of the Dcc1 mu-
tation (Downes and Koopman 2001).
Dcc4 homozygotes have completely black hair, simi-
lar to the phenotype of pigment type-switching muta-
tions such as Agouti, Atrn, or Mc1r. Complementation
crosses suggested that Dcc4 was an allele of Agouti, and
in PCR-amplified genomic DNA fromDcc4 homozygous
animals, we identified a missense alteration predicted to
cause a Met1Leu substitution at the translational initia-
tion site. The phenotype ofDcc4 homozygous animals is
similar to amorphic Agouti alleles, and suggests that the
Met1Leu mutation completely blocks translation of a
functional protein.
Discussion
Visible phenotypes are a mainstay of mutagenesis ex-
periments in most model organisms; of ∼ 400 mutations
identified in the screen that gave rise to the mutants
described here (Hrabé de Angelis et al. 2000), ∼ 10% af-
fected the hair or skin. Both of the Dcc mutants we ex-
amined represent new alleles of genes known previously
as coat color mutations, but the 10 Dsk mutants repre-
sent genes (Dsk2, Dsk5) or genetic map locations (Dsk1,
Dsk3, Dsk4, Dsk6, Dsk7, Dsk8, Dsk9, Dsk10) not im-
plicated previously in the pigmentary system (Table 1).
Our results demonstrate that the pathogenesis of dark
skin in mice can be separated into several genetic pro-
cesses, each represented by multiple mutations, and that
Figure 8. Phenotypic and molecular characterization of Dcc1. (a–c) C3HeB/FeJ–Dcc1/+ intercross progeny at 1 wk (a), 3 wk (b), and
3 mo (c) of age. For a and b, the genotypes, left to right, are +/+, Dcc1/+, and Dcc1/Dcc1. Heterozygous mutants exhibit a moderately
darkened coat and homozygous mutants exhibit almost complete darkening (yellow pigment is preserved in the whiskers) and sparse
hair growth. (d) A T-to-A transversion in genomic DNA of Dcc1mutant animals predicts a nonsense mutation in the transactivation
domain of the protein.
Genetics of dark skin in mice
GENES & DEVELOPMENT 223
molecular identification of these mutations can provide
insight into basic aspects of developmental biology and
models for human disease.
Development and pathophysiology of dark skin
Skin pigmentation in hairy regions of the mouse is most
apparent in the first few weeks of life, and is brought
about by epidermal melanocytes, large dendritic cells
that synthesize and transfer melanin-containing gran-
ules to surrounding keratinocytes (Quevedo and Hol-
stein 1998). These epidermal melanocytes differentiate
from so-called melanoblasts, small spindle-shaped cells
committed to the pigment cell lineage that do not yet
actively synthesize melanin, and have migrated exten-
sively, first from the neural crest, and later through der-
mal mesenchyme (Fig. 1a; Mackenzie et al. 1997;
Kunisada et al. 2000; Yoshida et al. 2001; Nishimura et
al. 2002). Thus, two major characteristics of the class I
mutationsDsk1,Dsk7, andDsk10—accumulation of ex-
cess melanin in the dermis rather than the epidermis,
and appearance of dark skin by 2–3 d of age before hair
follicle development is complete—indicate that these
mutations act relatively early in skin development, at a
stage when dermal melanoblasts normally choose be-
tween alternative fates, differentiation into dermal me-
lanocytes or continued migration across the dermal–epi-
dermal junction (Table 1; Fig. 1b). The underlying defect
inDsk1,Dsk7, andDsk10 could bias this choice, causing
an increased number of dermal melanocytes and a de-
creased number of migrating melanoblasts. In the epider-
mis, however, interfollicular pigmentation is normal,
and intrafollicular pigmentation, that is, hair color, is
slightly increased. Thus, a more likely explanation for
the underlying defect in Dsk1, Dsk7, and Dsk10 is an
overall increase of pigment cell precursors in all skin
compartments, but whose manifestations are apparent
mainly in the dermis and the intrafollicular epidermis
due to compensation by a postnatal mechanism that ac-
tively removes pigment cells from the epidermis. A de-
velopmental mechanism that actively eliminates mela-
nocytes from the interfollicular epidermis helps to ex-
plain why skin pigmentation in hairy regions of mice is
evident only in the first few weeks of age.
The few regions of the body in which normal skin
pigmentation is obvious in adult mice—tails, ears, and
footpads—are characterized by sparse or absent hairs and
large numbers of dermal melanocytes, and these regions
are prominently affected by Dsk1, Dsk7, and Dsk10. A
likely human counterpart is the “Mongolian spot”
(Kikuchi and Inoue 1980; Cordova 1981; Kikuchi 1989), a
localized accumulation of dermal melanocytes at birth
that gradually recedes with age and exhibits a bluish-
gray appearance, similar to what we observe in the foot-
pads of Dsk1, Dsk7, and Dsk10 mutant animals. The
molecular pathogenesis of Mongolian spots is obscure;
they are benign lesions that have not been described as a
Mendelian trait, but are clearly subject to genetic influ-
ences; reported in 1%–15% of Caucasians, 50%–90% of
Africans or African-Americans, and >80% of Asians.
Identification of the molecular lesions responsible for
Dsk1, Dsk7, or Dsk10 could help explain why dermal me-
lanocytes accumulate in this common human condition,
why their incidence varies among different ethnic groups,
and why there is a correlation among different ethnic
groups in the incidence of Mongolian spots and dark hair.
Accumulation of excess melanin in the class II muta-
tions Dsk3, Dsk4, Dsk6, and Dsk8 occurs in the epider-
mis and is not apparent until 2–3 wk of age, after hair
follicle development is complete (Table 1). Because none
of these mutations affect hair color, the underlying de-
fect must be limited to the transition between epidermal
melanoblast and epidermal melanocyte (Fig. 1b), and
could involve either an increase in melanocyte number,
or an increase in the production and transfer of melanin
to surrounding keratinocytes (Table 1; Fig. 1b). The latter
class is particularly interesting from the perspective of
human genetics, as normal variation in human skin
color is mediated by changes in melanocyte activity
rather than melanocyte number (Toda et al. 1972; Que-
vedo et al. 1975; Quevedo and Holstein 1998). Beside rare
mutations that cause oculocutaneous albinism, the only
human skin color gene identified to date is the mela-
nocortin 1 receptor, in which loss-of-function variants
cause fair skin and red hair (Rees et al. 1999; Sturm et al.
2001). Mc1r variation, however, accounts for a small
fraction of skin color variation in human populations; in
particular, little is known about the genetic basis for
skin color that correlates with equatorial proximity of
ancestral human populations, or how genes might con-
trol skin color independent of hair color (Robins 1991;
Jablonski and Chaplin 2000). The exact molecular le-
sions responsible for Dsk3, Dsk4, Dsk6, and Dsk8 are
unlikely to occur as human polymorphisms, because ho-
mozygotes are lethal. Nonetheless, identifying the path-
ways affected by Dsk3, Dsk4, Dsk6, and Dsk8 could pro-
vide insight into mechanisms that control normal varia-
tion in human skin color.
Epidermal thickening, melanocytosis, and Egfr signaling
Dsk2 and Dsk5 both cause epidermal thickening and an
increased number of epidermal melanocytes, yet the pri-
mary cell biologic abnormalities, keratinocyte fragility,
and increased Egfr signaling, respectively, are very differ-
ent. For both mutants, epidermal thickening is apparent
3–6 wk before dark skin, which points to an underlying
mechanism in which the release of one or more para-
crine factors from proliferating basal keratinocytes will
stimulate secondary proliferation of adjacent pigment
cells. Proliferation of basal keratinocytes in Dsk2 mu-
tant animals is itself secondary to a problem in su-
prabasal keratinocytes, as both the expression of Krt2e,
and the epidermal cytolysis in Dsk2mutant animals oc-
cur in the upper spinous layer. Hyperpigmentation is fre-
quently seen in human keratin disorders, not only ic-
thyosis bullosa of Siemens (KRT2E), but also in epider-
molytic hyperkeratosis caused by the spinous layer
keratins KRT1 or KRT10. Finally, basal cell carcinoma in
certain ethnic groups is almost always accompanied by
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epidermal melanocytosis (Maloney et al. 1992; Kikuchi
et al. 1996), and lentigenes (benign freckle-like spots that
occur in non sun-exposed areas) are associated with in-
creased numbers of melanocytes and increased keratino-
cyte proliferation (Lever and Schaumburg-Lever 1983).
Thus, epidermal melanocytosis may be a general conse-
quence of genetic or environmental lesions that cause
increased keratinocyte proliferation.
Phenotypic abnormalities in Dsk2mutant animals are
limited to the ears, tail, and footpads, and correlate with
the expression pattern of Krt2e, specific for these same
body regions (Herzog et al. 1994). In contrast, phenotypic
specificity in Dsk5 mutant animals must be explained
by sensitivity of the pigmentary system to slight pertur-
bations in Egfr signaling, because this pathway is used in
a wide variety of tissues and developmental stages. Al-
though Leu 863 is conserved in all closely related tyro-
sine kinases, a Gln occupies this position in phosphory-
lase kinase , a serine/theonine kinase that, like the Egfr,
is not phosphorylated within the activation loop (Owen
et al. 1995; Johnson et al. 1996). Thus, the Leu863Gln
substitution is unlikely to cause a substantial alteration
in conformation of the Egfr activation loop, but could
influence its interaction with the catalysis loop or ATP
binding. In either case, increased Egfr kinase activity
can account not only for epidermal thickening and
hyperkeratosis, but also for the reduction in steady-state
endogenous Egfr levels, as Egfr activation is directly
coupled to internalization and receptor turnover
(Schlessinger 1986; Felder et al. 1992). In fact, steady-
state down-regulation of the mutant receptor in vivo
probably contributes to the relatively mild whole-animal
phenotype, because a 5- to 10-fold increase in basal Egfr
signaling, as we observed in transiently transfected cells,
should have profound effects in several different organ
systems. Genetic or environmental perturbations that
interfere with receptor down-regulation may uncover
more dramatic phenotypes in Dsk5mutant animals, and
provide useful models for studying tumor progression
and/or treatment that depends on Egfr signaling.
Candidate genes and candidate phenotypes
The role of forward genetics in the post-genome era is
not yet clear, in part because strategies for obtaining ge-
notype-phenotype correlations based on knockout or as-
sociation-based approaches are potentially more efficient
than positional cloning (Grupe et al. 2001; Mitchell et al.
2001). Our results underscore the utility of focusing on a
specific biological process using a phenotype-driven ap-
proach; most of the mutations we identified would likely
have been overlooked in cursory screens, and a connec-
tion between melanocytosis and keratinocyte fragility or
Egfr signaling would likely not have been made in a se-
quence-driven screen. In addition, phenotypic character-
ization of Dsk1, Dsk3, Dsk4, Dsk6, Dsk7, Dsk8, Dsk9,
and Dsk10 has revealed distinct genetic steps in a devel-
opmental pathway for dark skin; although the genes
have not yet been cloned, this serves as a reminder that
analysis of mutant phenotypes can provide information
about a biological process as the molecular players are
being defined.
In the case of Dcc1, Dcc4, Dsk2, and Dsk5, likely po-
sitional candidates were easily identified with a low-
resolution (>5 cM) genetic map. The optimal map reso-
lution for efficient identification of the remaining Dsk
mutations is not yet clear, but as genomic sequence be-
comes more densely annotated, candidate genes can be
more accurately prioritized within a defined physical re-
gion, and positional cloning of mouse genes will become
more routine. Expansion of the Dsk screen will also in-
crease the efficiency of molecular identification by gen-
erating multiple alleles and by clarifying developmental
and cell biologic pathways that help to refine the selection
of candidate genes. Beside probable allelism be tweenDsk6
andDsk8, and betweenDsk1 andDsk10,Dsk4maps to the
same region as a mutation identified in the Harwell screen
(Nolan et al. 2000),Dark footpads 2 (Dfp2). Thus, 11 domi-
nant dark skin mutants likely map to 8 genetic loci, sug-
gesting that saturation of this screen is feasible.
Expansion of the Dsk screen will allow us to focus on
specific phenotypes that address additional components
of the dark skin pathway. For example, during the tran-
sition from dermis to epidermis, pigment cells switch
their pattern of cadherin expression from N- to E-cad-
herin; intrafollicular melanocytes that populate adult
hair follicles acquire expression of P-cadherin, whereas
melanocytes that disappear from the interfollicular epi-
dermis do not (Nishimura et al. 1999; Jouneau et al.
2000). Little is known about the mechanism that nor-
mally eliminates melanocytes from the interfollicular
epidermis; however, mutations that impair this pathway
should be recognized by the appearance of dark skin in
hair-bearing regions, and might be anticipated to im-
pinge on or interact with Kit signaling, as transgenic ex-
pression of Mgf in basal keratinocytes causes expansion
and promotes survival of interfollicular melanocytes
(Kunisada et al. 1998; Nishimura et al. 2002). Like the
Dsk mutations described here, this phenotype may not
be immediately apparent to casual observation, but
should be easy to detect in a directed screen. Similarly,
mutations that simultaneously increase one pigment
cell population while decreasing another, that is, dermal
melanocytosis associated with hair color dilution, might
identify genes that impair the ability of dermal melano-
blasts to switch their pattern of cadherin expression and
migrate across the dermal–epidermal junction.
Unlike hair color variants, Dsk mutations are not
“classical” in the sense of having been collected and
stored by mouse fanciers and large research colonies over
the last century. Nonetheless, like coat color, our results
indicate that differences in mouse skin color can reflect
subtle alterations in gene activity or gene dosage, and
suggest strategies for how mutagenesis screens might be
focused on specific biological questions using pigmenta-
tion as an indicator (Tsai et al. 2002). The mutations
described here were detected in a dominant screen, in
which gain-of-function alterations such as the Egfr
Leu863Gln substitution in Dsk5 reveal a positive regu-
lator of pigment cell development or activity. Although
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the logistics of a dominant screen are straightforward,
the ability to detect loss-of-function alterations is lim-
ited to the small fraction of genes that are haploinsuffi-
cient; loss-of-function mutations in Krt2e, Egfr, and
Sox18 have, or would likely have escaped detection in
the heterozygous state. Alternative strategies to recover
loss-of-function mutations use sensitized screens, or re-
cessive screens in the presence of large deficiencies or
balancer chromosomes (Frankel 2000; Justice 2000).
Availability of loss-of-function mutations that cause
dark skin will likely reveal negative regulators of pig-
ment cell development, and, therefore, provide informa-
tion complementary to the studies described here.
Materials and methods
Mouse genetics
In the initial mutagenesis and screening program at the GSF
(http://www.gsf.de/ieg), 14,000 animals were surveyed for
dominant mutations on the C3HeB/FeJ background. Among
186 mutants, 2 Dcc and 7 Dsk mutants were identified; in
screening an additional 10,000 animals, 5 more Dsk mutants
were recovered, including 3 described here. Except for Dcc4, all
mutants were maintained on the C3HeB/FeJ background. Dcc4
was identified originally as a dominant mutation but has been
maintained as a homozygous strain, C3HeB/FeJ-Dcc4/Dcc4, for
>15 generations. Back-crosses of Dcc4/Dcc4mice to C3HeB/FeJ
animals reveal that the coat color phenotype is now fully reces-
sive, which suggests that the original heterozygous phenotype
depended on the presence of an unlinked modifier that is no
longer present. The DctLacZ reporter transgene was con-
structed by Ian Jackson and colleagues (Mackenzie et al. 1997),
and obtained with his permission from Myung Shin on a mixed
background (CBA and C57BL/6J). For genetic interaction studies
of Dsk5, B6EiC3H–Egfrwa2/Wnt3avt animals were obtained
from The Jackson Laboratory.
For genetic mapping of Dsk1–Dsk9, we used a pooling strat-
egy, in which genomic DNA samples from 8–20 mutant back-
cross progeny [(C3HeB/FeJ+/− × C57BL/6J)F1 × C3H/He] were
compared with a pool of nonmutant back-cross progeny using a
genome-wide panel of simple sequence length polymorphism
(SSLP) markers, whose identities are available on request. Po-
tential linkage was verified with individual animals, and at least
100 back-cross progeny were scored for each mutation. Flanking






We determined the homozygous phenotype for Dsk1–Dsk9
by examining (C3HeB/FeJ–Dsk/+ × C57BL/6J)F1 intercross
progeny using molecular markers informative for the Dsk ge-
netic interval; at least 50 F2 progeny were examined for each
mutation (Table 1). All of the mutations exhibited an increase
in variability of expression on the mixed background used for
mapping; however, all were fully penetrant except for Dsk9, for
which homozygous lethality in F2 intercross animals was used
to determine a more accurate map position.
Histology
For each Dsk mutant strain, skin from 3–4-week-old mutant
and nonmutant littermates was removed from the footpads,
fixed in 4% paraformaldehyde, and embedded in paraffin; 7-µm
sections from all regions (volar pads and intervolar scales) were
stained with hematoxylin and eosin, and examined by light mi-
croscopy. Footpads from at least three animals were sectioned
for each mutant. For lacZ staining, Dsk2/+ or Dsk5/+ mutants
were crossed to the animals heterozygous for the DctLacZ re
porter transgene; skin samples from transgenic Dsk mutant and
nonmutant littermates were stained in parallel with Xgal and eo-
sin as described (Mackenzie et al. 1997). At least 40 sections were
examined from 2 sets of mutant and nonmutant littermates.
Molecular genetics
For Krt1, Krt2e, Agouti, and Sox18, genomic DNA prepared
from homozygous mutant and nonmutant tails was sequenced
directly after PCR amplification. For Egfr, PCR-amplified cDNA
was prepared from liver RNA of homozygous mutant and non-
mutant animals, cloned into pCR-TOPO (Invitrogen), and se-
quenced using vector primers. All mutations were verified by
examining genomic DNA in independent amplification reac-
tions from three or more mutant animals and comparison with
genomic DNA from the nonmutant strain of origin; oligo-
nucleotide primer sequences are available on request. No dif-
ferences between mutant and nonmutant sequences were de-
tected other than the variants presented in the Results section.
Causative lesions for Krt2e, Egfr, and Sox18 are presented in
Figures 4, 6, and 8, respectively; for Agouti (Dcc4), the causative
molecular lesion is an A-to-T transversion at the first position
of the translational initiation codon.
Dsk5 and Egfr
For interaction studies betweenDsk5 and Egfrwa2, progeny from
a C3HeB/FeJ–Dsk5/+ × B6EiC3H–Egfrwa2/Wnt3avt cross were
examined and scored blindly for the presence and extent of foot-
pad pigmentation. Presence of the Dsk5 mutation was deter-
mined by AluI digestion of PCR amplified (5-AGATGGTT
CACTCCCTCACG-3 and 5-ATGCTTCCTGATCTACTCCC
3) genomic DNA; the Dsk5 mutation introduces an AluI re-
striction enzyme site, and thus yields two fragments of 70 and
150 bp. The presence of the Egfr-wa2 allele was determined by
FokI digestion of PCR-amplified genomic DNA (http://jaxmice-
.jax.org/html/pricelist/wa2.pdf).
For Egfr immunohistochemistry, footpads and tails from
3-month-old animals carrying the DctLacZ transgene were
fixed and stained for lacZ as described above. Ten-micrometer
sections were cleared in Xylene, rehydrated in an ethanol series,
then treated for 10 min with 3% hydrogen peroxide, and washed
in PBS. Slides were blocked with 1.5% normal goat serum, then
incubated with a 1:500 dilution of Egfr antibody (sc-03, Santa
Cruz Biotechnology) overnight at 4°C. The next day, slides were
incubated with a 1:750 dilution of biotin-conjugated goat anti-
rabbit antibody for 1 h at room temperature, followed by detection
using the Vectastain Elite ABC kit (Vector laboratories). For the
negative control, slides were processed without primary antibody.
For Egfr detection in tissues, F2 progeny from a C3HeB/FeJ–
Dsk5/+ intercross were euthanized, genotyped as described
above, and livers from +/+, Dsk5/+, and Dsk5/Dsk5 animals
were dissected and homogenized on ice in 20 mM Hepes (pH
7.4), 1% Triton X-100, 2 mM EDTA, 2 mM EGTA, 500 µm
Na3VO4, 50 µM Na2Mo4O4 and a protease inhibitor cocktail
(1× Complete, Roche Molecular Biochemicals) as described in
Donaldson and Cohen (1992). Homogenates were centrifuged at
14,000 g in the cold room for 5 min, and the supernatants re-
tained as total cell lysates. Protein concentrations were deter-
mined using Coomassie Plus Reagent (Pierce Biochemicals), and
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150 µg of total protein per sample was analyzed by Western
blotting. Protein blots were incubated with anti-EGFR (sc-03,
Santa Cruz Biotechnology) or anti-phosphotyrosine antibody
(PY20, Santa Cruz Biotechnology), and detected using chemilu-
minescence (ECL, Amersham).
For studies with administration of EGF or phosphatase inhibi-
tors, animals genotyped as described above were injected sub-
cutaneously with 100 µL of PBS, with 0.1–5 µg EGF/g body
weight dissolved in PBS, or with 10 µL/g of body weight of a
phosphatase inhibitor solution (5 mM Na3VO4, 50 mM H2O2)
as described in Ruff et al. (1997). Twenty minutes after injec-
tion, animals were euthanized, livers dissected, and total cell
lysates obtained as described above.
For the cell culture studies, the Leu863Gln mutation was
introduced into an Egfr expression vector (pcDNA3.1, Invitro-
gen) by site-directed mutagenesis (GeneEditor, Promega) and
the entire coding region verified by sequence analysis. COS cells
at 50% confluency in a 6-well plate were transfected (FuGENE,
Roche Molecular Biochemicals) with either 1 or 2 µg of normal
or Egfr expression vector; for the 1 µg transfections, an addi-
tional 1 µg of GFP expression vector was added to verify and
compare transfection efficiency for different wells. After 18 h,
transfected cells were washed twice with cold PBS, and cell
lysates prepared by incubation in 100 µL of lysis solution (20
mM HEPES at pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton
X-100, 1 mM PMSF, 10 µg/mL leupeptin, 10 µg/mL aprotinin, 1
mM sodium vanadate, 10 mM -glycerophosphate) at 4°C for 15
min. The debris was cleared by centrifugation and protein con-
centration was measured using a Bradford assay (BioRad).An
equal amount (10 µg) of protein was separated on 6% SDS-
PAGE, transferred to PVDF membranes, and then treated as
described above.
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